Lupin Q2 Results 2024. 06 may 2024, 9:18 pm. This came after the pharma major reported its.
Lupin is the leader in 48 of its marketed generics in the u.s. Net profit jumps 52% to rs 359 crore, revenue up 13%.
Shares Of Pharmaceutical Company Lupin Slipped 5.2 Per Cent At Rs 1,591 On The Bse In Tuesdayโs Intraday Deals.
Commanded a market value of rs 29102.72 crore, according to bse.
Lupin Reported A 52% Yoy Growth In Net Profit To Rs 368 Crore For March 2024 Quarter.
And amongst the top 3 in 101 of its marketed products (iqvia september 2023).
The Nifty Bank Index Closed 0.62 Per Cent Down At 48923.55.
Images References :
Lupin Stock Declines 2.96% On The Nse, Trading At โน1,630 After Q4 Results May 07, 2024 10:01 Stock Market Live Updates:
Net profit jumps 52% to rs 359 crore, revenue up 13%.
Net Profit Of Lupin Rose 52.33% To Rs 359.43 Crore In The Quarter Ended March 2024 As Against Rs 235.96 Crore During The Previous Quarter Ended March.
The stock of lupin ltd.
And Amongst The Top 3 In 101 Of Its Marketed Products (Iqvia September 2023).